Paradigm Biopharmaceuticals Ltd is pleased to announce the results of its phase 2b randomised double-blind placebo-controlled multi-centre clinical trial.
Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.
Start the conversation
Ask Paradigm Biopharmaceuticals a question about this update.
